Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Longlife Bioscience is a biotechnology company based in Suzhou, China, specializing in high-throughput single-cell sequencing and multi-omics analysis. The company provides advanced platforms for precision medicine, enabling researchers and clinicians to analyze cellular heterogeneity at an unprecedented resolution. Their services and products support drug discovery, biomarker identification, and clinical diagnostics across oncology, immunology, and developmental biology. By integrating microfluidics, molecular biology, and bioinformatics, Longlife Bioscience aims to accelerate the development of personalized therapeutic strategies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Longlife.